Filing Details
- Accession Number:
- 0001127602-15-023479
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-27 17:03:14
- Reporting Period:
- 2015-07-27
- Filing Date:
- 2015-07-27
- Accepted Time:
- 2015-07-27 17:03:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202098 | Stelios Papadopoulos | Biogen Inc. 225 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-27 | 5,000 | $304.78 | 5,000 | No | 4 | P | Indirect | Esperanza Holdings, LLC |
| Common Stock | Acquisiton | 2015-07-27 | 5,000 | $304.98 | 5,000 | No | 4 | P | Indirect | Stelios Holdings, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Esperanza Holdings, LLC |
| No | 4 | P | Indirect | Stelios Holdings, LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,580 | Direct |
Footnotes
- Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares purchased at a range between $304.745 (low) and $304.939 (high).
- This represents the weighted average price for shares purchased at a range between $304.978 (low) and $304.98 (high).
Billionaire Hedge Funds
